Corticosteroids for Urological Cancer Care During Coronavirus Disease 2019. Treat or Not to Treat?
| Autor: | Waterhouse JV; Department of Oncology, University College London Cancer Institute, London, UK., Hull JH; Department of Respiratory Medicine, Royal Brompton Hospital, Imperial College, London, UK., Linch M; Department of Oncology, University College London Cancer Institute, London, UK. Electronic address: m.linch@ucl.ac.uk. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | European urology [Eur Urol] 2020 Jul; Vol. 78 (1), pp. 9-10. Date of Electronic Publication: 2020 Apr 21. |
| DOI: | 10.1016/j.eururo.2020.04.027 |
| Abstrakt: | The current World Health Organization guidance is not to start corticosteroids, but there is no robust evidence of risk in patients with cancer and coronavirus disease 2019. A risk-benefit analysis should be performed for each patient on the use of steroids in cancer care. (Copyright © 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|
Full Text from ScienceDirect